News

Oct. 16, 2023Press Release

Sysmex Obtains ISO 30414 Certification for Human Capital Reporting

- Implementing Human Capital Management to Achieve Sustainable Increase in Corporate Value -

Sysmex Corporation (HQ: Kobe, Japan; President: Kaoru Asano) announces that it obtained ISO 30414¹ certification, the international guidelines for human capital reporting, on October 16, 2023. This is the first such certification that has been granted for the manufacturing industry in Asia.

The field of sustainability management has seen a reaffirmation, in recent years, of the significance of intangible assets, particularly human resources, and transparent disclosure of such assets has now become a requirement.

Overseas, the United States Securities and Exchange Commission (SEC) mandated disclosure of human capital information for listed companies in 2020, and the draft European Sustainability Reporting Standards (ESRS) for disclosure of sustainability information in the European Union were released in 2023. In Japan, human capital reporting has become mandatory in annual securities reports from 2023 onward. Management and disclosure of human capital are therefore becoming increasingly important to companies.

Sysmex regards human capital as an important element for enhancing corporate sustainability and has made engagement a key indicator in its corporate strategy. In addition, it has identified “Realization of an Attractive Workplace” as one of its priority issues (materiality), and as well as expanding the portfolio of human resources that will drive growth toward realization of the Company’s long-term vision and implementing a common global human resource management system. Sysmex has worked to integrate and leverage its human capital data.

In accordance with the ISO 30414 international guidelines for human capital reporting, Sysmex has defined 58 metrics in 11 areas in line with its corporate strategy, and these were disclosed externally in the annual Sysmex Sustainability Data Book 2023 (Japanese version), to increase the accuracy, reliability, and transparency of this data. In order to enhance the quality of its human capital management, Sysmex will continuously gauge and improve linkage with its corporate strategy, productivity indices measuring the effect of investment in human capital, and employee experience data obtained from regular surveys of our corporate culture, leading to enhanced dialogue with stakeholders through internal and external disclosure.

At Sysmex, our long-term vision is “Together for a better healthcare journey.”² To realize this vision, we have positioned human capital as a source of corporate value creation, and we will continue to move forward with building an organization that will create innovation by allowing diverse human resources to work comfortably and demonstrate their capabilities.

ISO 30414 Certificate of Conformity

References

	Sysmex’s Sustainability https://www.sysmex.co.jp/en/csr/index.html

	Sysmex’s Materiality https://www.sysmex.co.jp/en/csr/management/materiality.html

	Sysmex Sustainability Data Book 2023 (Japanese version) *English version will be published by the end of October 2023. https://www.sysmex.co.jp/csr/report/index.html

Terminology

	1	ISO 30414: One of the management system standards of the International Organization for Standardization (ISO). This is a set of guidelines established as international indicators for quantifying, analyzing, and disclosing information on human capital. The guidelines comprise 58 metrics in 11 areas related to human capital, including productivity and diversity.
	2	Sysmex promotes the concept of a “healthcare journey”. We view the various healthcare-related events a person experiences throughout their lives (life stages), along with the corresponding processes these involve (such as treatment at healthcare institutions), as a “journey”. Through various collaborations, we aim to offer new value, to make each individual’s healthcare journey better, and to grow as an essential presence in society.

About Sysmex Corporation

Sysmex Corporation, headquartered in Kobe, Japan, is a global leader in in vitro diagnostics. Since its foundation in 1968, Sysmex has focused on diagnostics as the core of its business, and today, it supports the health of people in over 190 countries and regions worldwide. Sysmex continues to innovate in diagnostics, and to collaboratively create unique values in the areas of personalized medicine and novel treatments, under its long-term vision of "Together for a better healthcare journey." To realize this vision, Sysmex identifies and verifies prioritized Sustainable Development Goals (SDGs) and materiality (priority issues), thereby maintaining its growth as a company that generates both social and economic value. Through its unique technology, solutions, and co-creation with various partners, Sysmex delivers new value and addresses the universal desire of people to live longer and healthier lives. For more information about Sysmex, please visit www.sysmex.co.jp/en/.

FOLLOW US　

Information contained in the news release is current as of the date of the announcement,
but may be subject to change without prior notice.

Back to "News"